Literature DB >> 21159388

Reactive oxygen species and insulin resistance: the good, the bad and the ugly.

Tony Tiganis1.   

Abstract

Reactive oxygen species (ROS) contribute to the progression of various human diseases, including type 2 diabetes mellitus (T2DM). ROS can suppress the insulin response and contribute to the development of insulin resistance, a key pathological feature of T2DM. Paradoxically, ROS generated by NADP(H) oxidases at the plasma membrane and endomembranes might also be required for normal intracellular signaling. Growth factors, cytokines and hormones such as insulin promote the generation of ROS for the coordinated inactivation of protein tyrosine phosphatases and the promotion of tyrosine phosphorylation-dependent signaling. A recent study has established the potential of H(2)O(2) to enhance insulin sensitivity in vivo and attenuate the development of insulin resistance. Thus, ROS have the capacity to both promote and attenuate the insulin response. Here I review evidence indicating that ROS promote insulin sensitivity versus insulin resistance and discuss the potential complications associated with the widespread use of antioxidants.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159388     DOI: 10.1016/j.tips.2010.11.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  89 in total

1.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.

Authors:  K Loh; T L Merry; S Galic; B J Wu; M J Watt; S Zhang; Z-Y Zhang; B G Neel; T Tiganis
Journal:  Diabetologia       Date:  2011-11-29       Impact factor: 10.122

Review 2.  Linking mitochondrial bioenergetics to insulin resistance via redox biology.

Authors:  Kelsey H Fisher-Wellman; P Darrell Neufer
Journal:  Trends Endocrinol Metab       Date:  2012-02-02       Impact factor: 12.015

3.  Mapping eQTLs in the Norfolk Island genetic isolate identifies candidate genes for CVD risk traits.

Authors:  Miles C Benton; Rod A Lea; Donia Macartney-Coxson; Melanie A Carless; Harald H Göring; Claire Bellis; Michelle Hanna; David Eccles; Geoffrey K Chambers; Joanne E Curran; Jacquie L Harper; John Blangero; Lyn R Griffiths
Journal:  Am J Hum Genet       Date:  2013-12-05       Impact factor: 11.025

4.  In vitro analysis of antioxidant activities of Oxalis corniculata Linn. fractions in various solvents.

Authors:  Dildar Ahmed; Saman Zara; Hira Baig
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

5.  Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice.

Authors:  Fengmin Li; Jian Yang; Van Anthony M Villar; Laureano D Asico; Xiaobo Ma; Ines Armando; Hironobu Sanada; Minoru Yoneda; Robin A Felder; Pedro A Jose; Xiaoyan Wang
Journal:  Diabetologia       Date:  2017-10-28       Impact factor: 10.122

6.  Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2.

Authors:  Esteban N Gurzov; Melanie Tran; Manuel A Fernandez-Rojo; Troy L Merry; Xinmei Zhang; Yang Xu; Atsushi Fukushima; Michael J Waters; Matthew J Watt; Sofianos Andrikopoulos; Benjamin G Neel; Tony Tiganis
Journal:  Cell Metab       Date:  2014-06-19       Impact factor: 27.287

Review 7.  Disturbance of redox homeostasis as a contributing underlying pathomechanism of brain and liver alterations in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Guilhian Leipnitz; Carmen Regla Vargas; Moacir Wajner
Journal:  J Inherit Metab Dis       Date:  2015-06-04       Impact factor: 4.982

Review 8.  Neuroinflammatory basis of metabolic syndrome.

Authors:  Sudarshana Purkayastha; Dongsheng Cai
Journal:  Mol Metab       Date:  2013-10-05       Impact factor: 7.422

Review 9.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

10.  Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice.

Authors:  Troy L Merry; Melanie Tran; Garron T Dodd; Salvatore P Mangiafico; Florian Wiede; Supreet Kaur; Catriona L McLean; Sofianos Andrikopoulos; Tony Tiganis
Journal:  Diabetologia       Date:  2016-09-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.